Patent · US Active

Methods and compositions for treating decreased cognitive ability

US11969460B2 · kind B2 · utility

0Cited by

2References

11Claims

0Family size

Assignees

Saint Louis University · US
U.S. Department of Veternas Affairs · US

Inventors

Andrew Butler · Kirkwood, US
Susan Farr · Chesterfield, US
Clemence Girardet · Paris, FR

Key dates

Filing date	Jun 4, 2019
Grant date	Apr 30, 2024
Priority date	—
Expiry date	Jun 4, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K48/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are methods and compositions for treating cognitive decline in subjects in need. More specifically, disclosed are methods of administrating exogenous adropin to subjects suffering from, or at risk of, cognitive decline. Also disclosed are subjects who would benefit from such treatment and pharmaceutical acceptable compositions comprising adropin, adropin34-76, and derivatives or variations thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.